|
|
| Dear Friends,We recently got word that the FDA has sent warning letters to CBD companies about marketing an unapproved drug. This is the first time FDA has intervened to our knowledge in this way.
“Your products are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are ‘new drugs,’“ the FDA wrote to CBD Life Holdings in Arizona. “New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA…You should take prompt action to correct the violations cited in this letter.”
Similar letters were sent to Hemp Oil Care in California, Twin Falls Bio Tech in South Carolina, and three Washington State companies: Purecdb.net, Canna Pet, and Canna Companion. Canna Companion http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm435671.htm Canna Pethttp://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm435662.htm Pure CBD http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm436066.htm CBD Life Holdings http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm435778.htm Hemp Oil Care http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm436069.htm Twin Falls Bio Tech http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm435777.htm The warning letters can be found here. Let’s hope this is a sign of more intervention to come. Best, |
